(Q40595818)

21 September 2017

title

Vaccination against hepatitis A in children aged 12 to 24 months [corrected]. (English)

1 reference

21 September 2017

1 reference

Abarca K

1

1 reference

21 September 2017

Ibañez I

2

1 reference

21 September 2017

Flores J

3

1 reference

21 September 2017

Vial PA

4

1 reference

21 September 2017

Safary A

5

1 reference

21 September 2017

Potín M

6

1 reference

21 September 2017

publication date

1 September 2001

1 reference

Archives of Medical Research

21 September 2017

published in

1 reference

21 September 2017

volume

32

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

468-472

1 reference

Epidemiological patterns of hepatitis A in different parts of the world

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Hepatitis A in Latin America: a changing epidemiologic pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Hepatitis A shifting epidemiology in South-East Asia and China

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Hepatitis A shifting epidemiology in the Middle East and Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Hepatitis A shifting epidemiology in Poland and Eastern Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

The role of young children in a community-wide outbreak of hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Hepatitis A and B in children and adolescents – what can we learn from Puglia (Italy) and Catalonia (Spain)?

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Determinants of infant responses to vaccines in presence of maternal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Two-year review of hepatitis A vaccine safety: data from the Vaccine Adverse Event Reporting System (VAERS).

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

Response to Hepatitis A Vaccine in Children after a Single Dose with a Booster Administration 6 Months Later

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900309-5

7 January 2021

10.1016/S0188-4409(01)00309-5

Identifiers

DOI

1 reference

21 September 2017

1 reference